335 related articles for article (PubMed ID: 20335614)
21. Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice.
Inomata Y; Fukushima M; Hara R; Takahashi E; Honjo M; Koga T; Kawaji T; Satoh H; Takeya M; Sawamura T; Tanihara H
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3970-6. PubMed ID: 19182261
[TBL] [Abstract][Full Text] [Related]
22. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
23. Annexin A2 promotes choroidal neovascularization by increasing vascular endothelial growth factor expression in a rat model of argon laser coagulation-induced choroidal neovascularization.
Zhao SH; Pan DY; Zhang Y; Wu JH; Liu X; Xu Y
Chin Med J (Engl); 2010 Mar; 123(6):713-21. PubMed ID: 20368092
[TBL] [Abstract][Full Text] [Related]
24. Natural history of choroidal neovascularization after surgical induction in an animal model.
Lassota N; Kiilgaard JF; la Cour M; Scherfig E; Prause JU
Acta Ophthalmol; 2008 Aug; 86(5):495-503. PubMed ID: 18752525
[TBL] [Abstract][Full Text] [Related]
25. Krypton laser photocoagulation induces retinal vascular remodeling rather than choroidal neovascularization.
Behar-Cohen F; Benezra D; Soubrane G; Jonet L; Jeanny JC
Exp Eye Res; 2006 Aug; 83(2):263-75. PubMed ID: 16564044
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
He J; Bazan HE
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
[TBL] [Abstract][Full Text] [Related]
28. In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography.
Giani A; Thanos A; Roh MI; Connolly E; Trichonas G; Kim I; Gragoudas E; Vavvas D; Miller JW
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3880-7. PubMed ID: 21296820
[TBL] [Abstract][Full Text] [Related]
29. Caspase-8-mediated apoptosis in human RPE cells.
Yang P; Peairs JJ; Tano R; Zhang N; Tyrell J; Jaffe GJ
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3341-9. PubMed ID: 17591907
[TBL] [Abstract][Full Text] [Related]
30. Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury.
Berger S; Savitz SI; Nijhawan S; Singh M; David J; Rosenbaum PS; Rosenbaum DM
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3605-10. PubMed ID: 18660426
[TBL] [Abstract][Full Text] [Related]
31. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
Mochimaru H; Nagai N; Hasegawa G; Kudo-Saito C; Yaguchi T; Usui Y; Kurihara T; Koto T; Satofuka S; Shinoda H; Ozawa Y; Tsubota K; Kawakami Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4795-801. PubMed ID: 17898306
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
[TBL] [Abstract][Full Text] [Related]
33. Activation of caspase-8 by tumour necrosis factor receptor 1 is necessary for caspase-3 activation and apoptosis in oxygen-glucose deprived cultured cortical cells.
Badiola N; Malagelada C; Llecha N; Hidalgo J; Comella JX; Sabriá J; RodrÃguez-Alvarez J
Neurobiol Dis; 2009 Sep; 35(3):438-47. PubMed ID: 19555759
[TBL] [Abstract][Full Text] [Related]
34. Neutrophils promote experimental choroidal neovascularization.
Zhou J; Pham L; Zhang N; He S; Gamulescu MA; Spee C; Ryan SJ; Hinton DR
Mol Vis; 2005 Jun; 11():414-24. PubMed ID: 15988410
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells augment choroidal neovascularization.
Nakai K; Fainaru O; Bazinet L; Pakneshan P; Benny O; Pravda E; Folkman J; D'Amato RJ
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3666-70. PubMed ID: 18408184
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of an antibody to cryptic collagen type IV epitopes on choroidal neovascularization.
Jo N; Ju M; Nishijima K; Robinson GS; Adamis AP; Shima DT; Mailhos C
Mol Vis; 2006 Oct; 12():1243-9. PubMed ID: 17110907
[TBL] [Abstract][Full Text] [Related]
37. Preventing stem cell incorporation into choroidal neovascularization by targeting homing and attachment factors.
Sengupta N; Caballero S; Mames RN; Timmers AM; Saban D; Grant MB
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):343-8. PubMed ID: 15623794
[TBL] [Abstract][Full Text] [Related]
38. Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB.
Mohan RR; Mohan RR; Kim WJ; Wilson SE
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1327-36. PubMed ID: 10798647
[TBL] [Abstract][Full Text] [Related]
39. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125
[TBL] [Abstract][Full Text] [Related]
40. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin.
Tomida D; Nishiguchi KM; Kataoka K; Yasuma TR; Iwata E; Uetani R; Kachi S; Terasaki H
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3193-9. PubMed ID: 21296829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
